1995
DOI: 10.1016/s0022-3476(95)70090-0
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of essential thrombocythemia with anagrelide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
8
0

Year Published

1998
1998
2012
2012

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 15 publications
1
8
0
Order By: Relevance
“…In the series of Meisel et al [16], 11 out of 35 patients were asymptomatic, and 66% of patients presented with thrombosis-related symptoms, most commonly neurological, microcirculatory, or thromboembolic. Our patient, like two of the three patients of Chintagumpala et al [4], presented with severe headaches and abdominal pain.…”
Section: Lutz Hempel MD (Pediatric Oncologist)supporting
confidence: 63%
See 4 more Smart Citations
“…In the series of Meisel et al [16], 11 out of 35 patients were asymptomatic, and 66% of patients presented with thrombosis-related symptoms, most commonly neurological, microcirculatory, or thromboembolic. Our patient, like two of the three patients of Chintagumpala et al [4], presented with severe headaches and abdominal pain.…”
Section: Lutz Hempel MD (Pediatric Oncologist)supporting
confidence: 63%
“…Chintagumpala et al [3] published successful treatment of ET with anagrelide in an 11-year-old boy in 1991; and in 1995, successful treatment of two further children [4]. The anagrelide study group reported on 577 patients with myeloproliferative diseases, including 335 patients with ET in 1992 [5].…”
Section: Lutz Hempel MD (Pediatric Oncologist)mentioning
confidence: 99%
See 3 more Smart Citations